Olink Holding AB (publ)
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OLK research report →
About the company
Olink Holding AB (publ) offers a comprehensive suite of products and services tailored for life science research institutions, including academic bodies, government entities, biopharmaceutical companies, and biotechnology firms. The company's product lines include Olink Explore, which is designed to aid research in critical areas such as cardiovascular and metabolic health, oncology, neurology, and inflammation. Additionally, it features the Olink Target product line and the Olink Focus product line, the latter providing bespoke solutions for clients who have already pinpointed specific proteins or protein signatures for their studies.
- CEO
- Jon Heimer
- IPO
- 2021
- Employees
- 707
- HQ
- Uppsala, SE
Price Chart
- Market Cap
- $3.24B
- P/E
- -100.31
- P/S
- 19.09
- P/B
- 6.43
- EV/EBITDA
- -101.88
- Div Yield
- 0.00%
- Gross Margin
- 58.19%
- Op Margin
- -29.39%
- Net Margin
- -18.63%
- ROE
- -6.93%
- ROIC
- -7.18%
- Revenue
- $169.91M · 21.49%
- Net Income
- $-31,657,721 · -146.34%
- EPS
- $-0.26 · -136.36%
- Op Income
- $-49,940,060
- FCF YoY
- -32.94%
- 52W High
- $26.09
- 52W Low
- $14.10
- 50D MA
- $24.39
- 200D MA
- $23.55
- Beta
- 0.52
- Avg Volume
- 545.96K
Get TickerSpark's AI analysis on OLK
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our OLK coverage
Recent articles, reports, and earnings notes.
No research on OLK yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OLK report →Similar companies
Peers in the same neighborhood.